(Q43085229)

English

Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study

scientific article published in February 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

ocular hypertension

1 reference

based on heuristic

inferred from title

open-angle glaucoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Hannu Uusitalo

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

author name string

Lutz E Pillunat

2

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Auli Ropo

3

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Phase III Study Investigators

4

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

publication date

1 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Acta Ophthalmologica

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

12-19

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.01862.X

21 January 2018

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.01862.X

21 January 2018

Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.01862.X

21 January 2018

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.01862.X

21 January 2018

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.01862.X

21 January 2018

Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.01862.X

21 January 2018

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-3768.2010.01862.X

21 January 2018

Identifiers

10.1111/J.1755-3768.2010.01862.X

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43085229&oldid=2093155908"